“In-Home care is considered the oldest and most respected form of health care”


About Drugwatch.com

Drugwatch.com advocates for consumers injured by prescription drugs and medical devices. We also provide information about recalls and lawsuits.

Click here to learn more


Invokana belongs to a newer class of Type 2 diabetes treatments called sodium-glucose cotransporter 2 (SGLT2) inhibitors, a class of medication that works by stopping glucose from being reabsorbed into the blood. The FDA warned Invokana can also cause ketoacidosis, a condition that requires hospitalization and can cause fatal swelling of the brain, severe dehydration and coma.

Click here to learn more